Clinical Trial Update: Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study) [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating echinocandin antifungals in patients with septic shock following secondary peritonitis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritonitis
• Septic Shock

Drugs mentioned

• echinocandin class (echinocandin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Septic Shock, Peritonitis | Phase 4 | Status: COMPLETED